bioMérieux Stock Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.91B 4.17B | Sales 2025 * | 4.19B 4.47B | Capitalization | 11.83B 12.62B |
---|---|---|---|---|---|
Net income 2024 * | 471M 502M | Net income 2025 * | 529M 564M | EV / Sales 2024 * | 2.94 x |
Net cash position 2024 * | 348M 372M | Net cash position 2025 * | 590M 630M | EV / Sales 2025 * | 2.68 x |
P/E ratio 2024 * |
25.7
x | P/E ratio 2025 * |
22.9
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
0.97% | Free-Float | 35.51% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
-19.65% | 6.89B | |
-2.87% | 4.95B | |
-7.82% | 4.28B | |
-0.84% | 4.23B | |
-47.89% | 3.67B | |
+8.57% | 2.62B | |
-6.37% | 2.31B | |
-2.61% | 1.7B | |
-25.39% | 1.47B |